Â© juan moyano / Alamy
The virus now threatens many areas of the United States. As the virus spreads, researchers across the globe are working tirelessly to learn more about the virus and to discover therapeutics and possibly a vaccine. Unfortunately, the pace of laboratory work is intrinsically slow and results may take years to develop.
The fact that there are still approximately 2 million people around the world who receive an HIV-positive diagnosis each year only accentuates how important it is to scale-up proven combination prevention approaches. Equally important is the scale-up of investments to find a safe, effective and affordable vaccine and multi-purpose prevention technologies.
I am in Sierra Leone to visit some of the Ebola treatment centres run by Doctors Without Borders/ Médecins Sans Frontières (MSF) in response to the West African epidemic that began just over one year ago. That the Prince of Wales centre in Freetown, and other Ebola centres are closing is a sign case numbers have plummeted from the historic highs seen in the outbreak.
TORONTO - Earlier this week, U.S. President Barack Obama signed into law a little piece of legislation that may significantly change the economics of making drugs or vaccines to protect against Ebola...
Our organization works mainly in conflict-affected and unstable settings. Of these, we have chosen three to watch in 2014. In each country, governments are unable or unwilling to care for their populations, the ability of aid actors to respond has been curtailed, and populations are left to fend for themselves.